Pharmacotherapy for Poststroke Cognitive Impairment and Poststroke Cognitive Impairment With Dementia: A Review.

Stroke Res Treat · 2025 · PMC12103972 · PMID 40421258

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rivastigmine group exhibited slight enhancements in the Color Trails Test scores; however, these improvements did not reach statistical significance [ 32 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.